These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 25467091)

  • 1. Asymmetric dimethylarginine and long-term adverse cardiovascular events in patients with type 2 diabetes: relation with the glycemic control.
    Hsu CP; Hsu PF; Chung MY; Lin SJ; Lu TM
    Cardiovasc Diabetol; 2014 Dec; 13():156. PubMed ID: 25467091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma asymmetric dimethylarginine predicts death and major adverse cardiovascular events in individuals referred for coronary angiography.
    Lu TM; Chung MY; Lin MW; Hsu CP; Lin SJ
    Int J Cardiol; 2011 Dec; 153(2):135-40. PubMed ID: 21794936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of dimethylarginine dimethylaminohydrolase 1 gene polymorphism with type 2 diabetes: a cohort study.
    Lu TM; Lin SJ; Lin MW; Hsu CP; Chung MY
    Cardiovasc Diabetol; 2011 Feb; 10():16. PubMed ID: 21303562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymmetric dimethylarginine predicts cardiovascular events in patients with type 2 diabetes.
    Krzyzanowska K; Mittermayer F; Wolzt M; Schernthaner G
    Diabetes Care; 2007 Jul; 30(7):1834-9. PubMed ID: 17456842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes.
    Tarnow L; Hovind P; Teerlink T; Stehouwer CD; Parving HH
    Diabetes Care; 2004 Mar; 27(3):765-9. PubMed ID: 14988299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of asymmetric dimethylarginine in patients with cardiac syndrome X.
    Lu TM; Lee TS; Lin SJ; Chan WL; Hsu CP
    PLoS One; 2017; 12(12):e0188995. PubMed ID: 29206850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum asymmetric dimethylarginine and arginine levels predict microvascular and macrovascular complications in type 2 diabetes mellitus.
    Ganz T; Wainstein J; Gilad S; Limor R; Boaz M; Stern N
    Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27393712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymmetric dimethylarginine predicts clinical outcomes in ischemic chronic heart failure.
    Hsu CP; Lin SJ; Chung MY; Lu TM
    Atherosclerosis; 2012 Dec; 225(2):504-10. PubMed ID: 23092827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between serum asymmetric dimethylarginine levels and subjective sleep quality in normotensive patients with type 2 diabetes mellitus.
    Aribas A; Kayrak M; Tekinalp M; Akilli H; Alibasic H; Yildirim S; Gunduz M; Taner A; Unlu A
    Korean J Intern Med; 2015 May; 30(3):316-24. PubMed ID: 25995662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.
    Lajer M; Tarnow L; Jorsal A; Teerlink T; Parving HH; Rossing P
    Diabetes Care; 2008 Apr; 31(4):747-52. PubMed ID: 18162497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma concentrations of asymmetric-dimethyl-arginine in type 2 diabetes associate with glycemic control and glomerular filtration rate but not with risk factors of vasculopathy.
    Päivä H; Lehtimäki T; Laakso J; Ruokonen I; Rantalaiho V; Wirta O; Pasternack A; Laaksonen R
    Metabolism; 2003 Mar; 52(3):303-7. PubMed ID: 12647267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymmetric dimethylarginine in young people with Type 1 diabetes: a paradoxical association with HbA(1c).
    Marcovecchio ML; Widmer B; Turner C; Dunger DB; Dalton RN
    Diabet Med; 2011 Jun; 28(6):685-91. PubMed ID: 21294768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention.
    Lu TM; Ding YA; Lin SJ; Lee WS; Tai HC
    Eur Heart J; 2003 Nov; 24(21):1912-9. PubMed ID: 14585249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An assessment of correlation between serum asymmetric dimethylarginine and glycated haemoglobin in patients with type 2 diabetes mellitus.
    Začiragić A; Huskić J; Mulabegović N; Avdagić N; Valjevac A; Hasić S; Jadrić R
    Bosn J Basic Med Sci; 2014 Feb; 14(1):21-4. PubMed ID: 24579966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric dimethylarginine and clinical outcomes in chronic kidney disease.
    Lu TM; Chung MY; Lin CC; Hsu CP; Lin SJ
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1566-72. PubMed ID: 21642363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymmetric dimethylarginine predicts major adverse cardiovascular events in patients with advanced peripheral artery disease.
    Mittermayer F; Krzyzanowska K; Exner M; Mlekusch W; Amighi J; Sabeti S; Minar E; Müller M; Wolzt M; Schillinger M
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2536-40. PubMed ID: 16931791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel predictor of restenosis and adverse cardiac events: asymmetric dimethylarginine.
    Ari H; Ari S; Erdoğan E; Tiryakioğlu O; Ustündağ Y; Huysal K; Koca V; Bozat T
    Heart Vessels; 2010 Jan; 25(1):19-26. PubMed ID: 20091394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cause-specific risk of major adverse cardiovascular outcomes and hypoglycemic in patients with type 2 diabetes: a multicenter prospective cohort study.
    Sun B; He F; Sun L; Zhou J; Shen J; Xu J; Wu B; Liu R; Wang X; Xu H; Chen X; Zhou H; Liu Z; Zhang W
    Endocrine; 2019 Jan; 63(1):44-51. PubMed ID: 30121774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymmetric dimethylarginine, cortisol/cortisone ratio, and C-peptide: markers for diabetes and cardiovascular risk?
    Anderson JL; Carlquist JF; Roberts WL; Horne BD; May HT; Schwarz EL; Pasquali M; Nielson R; Kushnir MM; Rockwood AL; Bair TL; Muhlestein JB;
    Am Heart J; 2007 Jan; 153(1):67-73. PubMed ID: 17174641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of endothelial dysfunction with cardiovascular risk factors and new-onset diabetes mellitus in patients with hypertension.
    Triches CB; Mayer S; Quinto BMR; Batista MC; Zanella MT
    J Clin Hypertens (Greenwich); 2018 May; 20(5):935-941. PubMed ID: 29604155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.